|
市場調査レポート
糖尿病のMSL（メディカルサイエンスリエゾン）プログラムのためのツールキット
The Toolkit for Diabetes MSL Programs
|
Abstract
Build a world-class diabetes MSL program
Currently, about 246 million people worldwide have diabetes; this number is
expected to increase to 380 million by 2025, according to the International
Diabetes Foundation. Such staggering figures solidify diabetes' position as a
primary therapeutic area. They also indicate the value of medical science
liaisons who are building relationships within the diabetes medical community.
Today' s MSLs are key strategic drivers for product and overall company
success. Perhaps your company plans to enter the market or maybe your diabetes
MSL team needs an upgrade. In either case, The Toolkit for Diabetes MSL
Programs provides clear, easy-to-access guidance on all aspects of diabetes
MSL program management. The research focuses on these core areas:
- MSL structure and staffing
- MSL budgets
- MSL responsibilities and activities metrics
- KOL relationships and segmentation criteria
- MSL qualifications and experience levels
- KOL compensation
CEI has integrated its leading research in MSLs and thought leader management
with a growing expertise in therapeutic areas to create a highly customized,
data-driven report. You won' t find this information anywhere else! Use The
Toolkit or Diabetes MSL Programs to strengthen your diabetes MSL team and
improve the bottom line.
Table of Contents
The report' s five chapters contain these metrics:
Chapter 1: Structures and Staffing
- Average age of formal programs
- Total MSL FTEs - companywide
- Number of MSLs per diabetes program teams
- MSL programs' organizational structures
- MSL teams' alignment
- Executive oversight of MSL programs
- MSL department reporting relationships
Chapter 2: MSL Functions and Communications
- MSL teams' involvement in the product lifecycle
- Number of sales representatives
- Number of brands supported per each MSL
- MSLs' time dedicated to:
- Talking to doctors in the field
- Performing educational activities
- Researching clinical findings
- Speaking opportunities
- Providing information to managed care organizations
- Frequency of MSL communications via e-mail, face-to-face visits and
telephone.
Chapter 3: Targeting Diabetes Opinion Leader Segments
- Number of KOL Relationships per MSL
- Percentage of KOL relationships - for specialists, primary care
providers, and allied health
- Opinion leader selection factors
- Segmentation criteria for endocrinology
- Profiles for thought leaders in Tiers 1 through 5
- Minimum and maximum consulting hourly rates for Type 1 and Type 2 diabetes
thought leaders - broken down by company size (mid-sized and large) and by
provider category
- Average speaker fees for Type 1 and Type 2 diabetes thought leaders -
broken down by company size (mid-sized and large) and provider category
- Average advisory panel fees for Type 1 and Type 2 diabetes thought leaders
- broken down by company size (mid-sized and large) and by provider category
- Average author fees for Type 1 and Type 2 diabetes thought leaders -
broken down by company size (mid-sized and large) and by provider category
Chapter 4: MSL Background and Credentials
- Preferred levels of MSL education working with primary-care physician KOL
- Preferred levels of MSL education working with endocrinology KOLs
- Average MSL years of experience
- Entry-level salary MSLs working with PCP KOLs
- Entry-level salary MSLs working with endocrinology KOLs
- Criteria used to establish size of MSL teams
Chapter 5: Other Key Metrics
- Total MSL budgets by company
- MSL budgets by company - US only
- MSL budget distribution - US versus ROW
- MSL budgets by company - ROW only
- Percentage of companies with an MSL program outside of the US
- Budget contribution per department
|
